SFMG Wealth Advisors’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$160K Hold
22,153
– – 0.01% 312
2026
Q2
$221K Hold
22,153
– – 0.01% 296
2026
Q1
$160K Buy
+22,153
New +$142K 0.01% 305
2025
Q4
– Sell
-25,031
Closed -$154K – 325
2025
Q3
$154K Hold
25,031
– – 0.01% 292
2025
Q2
$122K Hold
25,031
– – 0.01% 269
2025
Q1
$92.6K Buy
+25,031
New +$107K 0.01% 269

Other funds holding SLDB

SFMG Wealth Advisors's SLDB Position: Q3 2026 in Review

SFMG Wealth Advisors held its Solid Biosciences (SLDB) position steady in Q3 2026 at 22,153 shares worth $160K. The position accounts for 0.01% of the portfolio, ranked #312.

SFMG Wealth Advisors first reported a position in SLDB in Q1 2025 and has held it in 6 quarters since. The position peaked at $221K in Q2 2026. 158 funds tracked by Wall St. Rank hold SLDB as of Q3 2026.

  • SFMG Wealth Advisors held 22,153 shares of Solid Biosciences worth $160K as of Q3 2026.
  • SFMG Wealth Advisors left its Solid Biosciences share count unchanged in Q3 2026.
  • Solid Biosciences made up 0.01% of SFMG Wealth Advisors's portfolio in Q3 2026, its #312 holding.
  • SFMG Wealth Advisors first reported a position in Solid Biosciences in Q1 2025 and has held it in 6 quarters since.
  • SFMG Wealth Advisors's Solid Biosciences position peaked at $221K in Q2 2026.
  • 158 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2026.

Based on SFMG Wealth Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.